Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 1,105	$ 1,696	$ 2,532	$ 2,985
Impairment of intangible assets				14,007
General and administrative	3,051	3,146	5,292	6,159
Total operating expenses	4,156	4,842	7,824	23,151
Loss from operations	(4,156)	(4,842)	(7,824)	(23,151)
Other income (expenses)
Income from sale of IP				1,780
Interest income	3	5	7	5
Interest expense	(142)	(33)	(234)	(72)
Loss on investment		(34)		(70)
Foreign exchange gains (losses)	(26)	(269)	69	(538)
Change in fair value adjustment of derivative and warrant liabilities	1,941	874	2,250	13,440
Penalty on Series A Preferred Stock liability		(800)		(800)
Net other income (loss)	1,776	(257)	2,092	13,745
Net loss for the period before tax expense	(2,380)	(5,099)	(5,732)	(9,406)
Income tax benefit (expense)		(4)		1,223
Net loss	(2,380)	(5,103)	(5,732)	(8,183)
Deemed dividend on Series C Preferred Stock	(119)		(123)
Deemed dividends on Series A Preferred Stock	(7,287)		(7,287)	(1,572)
Cash paid on converted Series A Preferred Stock		(1,377)		(1,511)
Net loss attributable to common stockholders	$ (9,786)	$ (6,480)	$ (13,142)	$ (11,266)
Basic net loss per common stock (in Dollars per share)	$ (26.28)	$ (53.9)	$ (66.82)	$ (97.63)
Weighted-average number of common stock outstanding, Basic (in Shares)	372,414	120,223	196,677	115,394
Other comprehensive loss, net of tax:
Net loss	$ (2,380)	$ (5,103)	$ (5,732)	$ (8,183)
Change in cumulative translation adjustment	(29)	(414)	55	(628)
Comprehensive loss attributable to common stockholders	$ (2,409)	$ (5,517)	$ (5,677)	$ (8,811)